01 1Curia Italy S.r.l.
02 1Fagron Services BV
03 1Medisca Inc.
04 1TAPI Czech Industries s.r.o.
05 1Teva Czech Industries s.r.o
01 2Dihydroergotoxine Mesylate
02 1ERGOLOID MESYLATES
03 2Ergoloid Mesylates
01 1Israel
02 1Netherlands
03 2U.S.A
04 1Blank
NDC Package Code : 55486-1574
Start Marketing Date : 2012-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76003-0338
Start Marketing Date : 2010-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0860
Start Marketing Date : 2017-08-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 47848-002
Start Marketing Date : 2022-11-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84644-002
Start Marketing Date : 2022-11-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
25
PharmaCompass offers a list of Dihydroergotoxine Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydroergotoxine Mesylate manufacturer or Dihydroergotoxine Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydroergotoxine Mesylate manufacturer or Dihydroergotoxine Mesylate supplier.
PharmaCompass also assists you with knowing the Dihydroergotoxine Mesylate API Price utilized in the formulation of products. Dihydroergotoxine Mesylate API Price is not always fixed or binding as the Dihydroergotoxine Mesylate Price is obtained through a variety of data sources. The Dihydroergotoxine Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dihydroergotoxine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroergotoxine Mesylate, including repackagers and relabelers. The FDA regulates Dihydroergotoxine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroergotoxine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroergotoxine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroergotoxine Mesylate supplier is an individual or a company that provides Dihydroergotoxine Mesylate active pharmaceutical ingredient (API) or Dihydroergotoxine Mesylate finished formulations upon request. The Dihydroergotoxine Mesylate suppliers may include Dihydroergotoxine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroergotoxine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dihydroergotoxine Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dihydroergotoxine Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dihydroergotoxine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dihydroergotoxine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dihydroergotoxine Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dihydroergotoxine Mesylate suppliers with NDC on PharmaCompass.
We have 4 companies offering Dihydroergotoxine Mesylate
Get in contact with the supplier of your choice:
